McIlrath & Eck’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
McIlrath & Eck's BCAT Position: Q1 2026 in Review
McIlrath & Eck increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 170% in Q1 2026, buying an estimated $29K and bringing the position to 3,130 shares worth $44.2K. The position accounts for ﹤0.01% of the portfolio, ranked #577.
McIlrath & Eck first reported a position in BCAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $44.4K in Q3 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- McIlrath & Eck held 3,130 shares of BlackRock Capital Allocation Term Trust worth $44.2K as of Q1 2026.
- McIlrath & Eck bought 1,969 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $29K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #577 holding.
- McIlrath & Eck first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and has held it in 14 quarters since.
- McIlrath & Eck's BlackRock Capital Allocation Term Trust position peaked at $44.4K in Q3 2025.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.